The Journal of Thoracic and Cardiovascular Surgery
Volume 117, Issue 4 , Pages 759-765 , April 1999

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic study

Received 27 April 1998 ,Revised 8 September 1998 ,Accepted 10 December 1998.

References 

  1. Sugarbaker DJ, Garcia JP. Multimodality therapy for malignant pleural mesothelioma. Chest. 1997;112:272–275
  2. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest. 1993;103:282S–284S
  3. Sugarbaker DJ, Strauss GM, Lynch TO, Richards W, Mentzer SJ, Lee TH, et al.  Node status has prognostic significance in the multimodality therapy of diffuse malignant mesothelioma. J Clin Oncol. 1993;11:1172–1178
  4. Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D, et al.  Intrapleural cisplatin and mitomycin for malignant mesothelioma following pneumonectomy: pharmacokinetic studies. J Clin Oncol. 1992;10:1001–1006
  5. Yasumoto K, Shimokawa T, Nagashima A, Hirose N, Nakahashi H. Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer. J Surg Oncol. 1993;54:67–70
  6. Lerza R, Esposito M, Vannozzi M, Bottino GB, Bogliolo G, Pannacciulli I. High dose of intrapleural cisplatin in a case of malignant pleural mesothelioma. Cancer. 1994;73:79–84
  7. Fujimura T, Yonemura Y, Nojima N, Nakai M, Kaji M, Sahara H, et al.  Intrathoracic hyperthermochemotherapeutic perfusion for the intrathoracic malignancies in gastric cancer. Hepatogastroenterology. 1995;42:878–884
  8. Matsuzaki Y, Shibata K, Yoshioka M, Inoue M, Sekiya R, Onitsuka T, et al.  Intrapleural perfusion hyperthermic chemotherapy for malignant pleural dissemination and effusion. Ann Thorac Surg. 1995;59:127–131
  9. Carry PY, Gilly FN, Petit PY, Sayag AC, Petit PY, Rochette C, et al.  A new device for treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report. Oncology. 1993;50:348–352
  10. Rusch VW. Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer. 1995;12(suppl):127–146
  11. Pass HI, Krandak K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215–222
  12. Sugarbaker DJ, Mentzer SJ, DeCamp M, Lynch TO, Strauss GM. Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma. Chest. 1993;103:377–381
  13. Ratto GB, Toma S, Civalleri D, Passerone GC, Esposito M, Zaccheo D, et al.  Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg. 1996;112:614–622
  14. Rusch VW, Figlin R, Godwin D, Piantadosi S. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a lung cancer study group trial. J Clin Oncol. 1991;9:313–319
  15. Ma GY, Bartlett DL, Reed E, Figg WD, Lush RM, Lee KB. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal mesothelioma. Cancer J Sci Am. 1997;3:174–179
  16. Ratto GB, Esposito M, Vannozzi M, Fulco RA, Rovida S. Experimental models of regional chemotherapy via the pulmonary artery using cisplatin. Reg Cancer Treat. 1990;3:222–227
  17. Baldini EH, Recht A, Strauss GM, DeCamp MM, Swanson SJ, Liptay MJ, et al.  Patterns of failure ofter trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997;63:334–338
  18. Colleoni M, Sartori F, Calabro F, Nelli P, Vicario G, Sgarbossa G, et al.  Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori. 1996;82:53–56
  19. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol. 1995;60:262–267
  20. Los G, vanVugt MJH, Pinedo HM. Response to peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin and carboplatin. Br J Cancer. 1994;69:235–241
  21. Takahashi I, Maehara Y, Kusumoto H, Kusumoto T, Baba H, Kohnoe S, et al.  Interaction of cis-diammine-dichloroplatinum (II) and its analogues cis-1,1-cyclobutanedycarboxylato 2R-2- methyl -1,4- butanediammineplatinum (II) and cis-diammine (glycolato) platinum with hyperthermia in vivo. Oncology. 1996;53:68–72
  22. Ohtsubo T, Saito H, Tanaka N, Tsuzuki H, Daito T, Gano E. In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharingeal carcinoma KB cells. Chemotherapy. 1997;43:43–50
  23. Storm FK, Kaiser LR, Silberman A, Harrison WH, Elliot RS, Morton DL. Thermo-chemotherapy for melanoma metastases in liver. Cancer. 1982;49:1243–1248
  24. Formenti SC, Shrivastava PN, Sapozink M, Jozsef G, Chan KK, Jeffers S, et al.  Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology. Int J Radiat Oncol Biol Phys. 1996;35:993–1001
  25. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol. 1996;14:1007–1017

☆ Address for reprints: Giovanni B. Ratto, MD, Istituto di Anatomia Chirurgica, Largo Rosanna Benzi 8, Università di Genova, 16132 Genova, Italy.

☆☆ 12/1/96534

PII: S0022-5223(99)70297-7

The Journal of Thoracic and Cardiovascular Surgery
Volume 117, Issue 4 , Pages 759-765 , April 1999

Article Tools

* Image Usage & Resolution